Inhibikase Therapeutics Inc (IKT)
Operating Cash Flow Growth
-123.23%
Quarterly · Period ending:
IKT Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-123.23%period ending
Latest reported-123.23%period ending
IKT Quarterly Cash from Operations YoY % (-32.04% → -123.23%)
Year-over-year change
High-resolution chart · PNG
IKT operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -123.2346% | |
| -193.8865% | |
| -40.6018% | |
| -117.0152% | |
| -10.2853% | |
| -6.1161% | |
| -55.2849% | |
| -18.9035% | |
| -10.7107% | |
| 35.2489% | |
| 3.2039% | |
| 25.4261% | |
| -4.8117% | |
| -51.8005% | |
| 13.1706% | |
| -172.4442% | |
| -2.5735% | |
| 0.0006% | |
| -332.7201% | |
| -2,775.6247% | |
| -39,702.3807% | |
| -1,440.2221% | |
| -14,952.1575% | |
| 1,210.3514% | |
| 78.2886% | |
| 11.5301% | |
| -551.4667% | |
| -32.0368% |